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Background: The aims of this study were to evaluate the antidiabetic activity and to detect molecular size of
Pseudostellaria heterophylla polysaccharide (PHP). Pseudostellaria heterophylla is a medicine extensively used in
traditional Chinese medicine formulas to treat diabetes and its complications.
Methods: Molecular weight of PHP was determined by gel permeation chromatography combined with
phenol-sulphuric acid method and the monosaccharides composition was determined by HPLC with a precolumn
derivatization. Four polysaccharides with different molecular weight were compared for hypoglycemic active on
two animal models both high does alloxan induced type1 diabetic mellitus (T1DM) and high-fat/lower does
streptozotocin induced type2 diabetic mellitus (T2DM). Blood sugar, glucose tolerance, and insulin tolerance were
detected. Rat serum IL-1β, IL-2, IL-10, Leptin, TNF-α, Acrp30 and CRP were also analyzed by sandwich-ELISA
approaches to preliminary probe the hypoglycemic mechanism of PHP.
Results: The hypoglycemic effects related to molecular size of polysaccharide were more effective against T2DM
than T1DM. PHP comprise four monosaccharides of galacturonic acid, glucose, galactose and arabinos. T2DM rats
daily receiving oral dose of polysaccharide(100 ~ 400 mg/kg) with 50 ~ 210 kDa molecular weight (PF40) could not
only significantly lower blood sugar but also reduce total triglyceride level in serum. PF40 improves in insulin
tolerance inhibited the expression of some biomarkers including inflammatory cytokine TNF-α and elevated anti-
inflammatory cytokine IL-10, regulated adiponectin Acrp30 and leptin.
Conclusions: PF40 prevent the cascade of inflammatory events in the treatment of T2DM to block overweight
progresses to obesity.
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Diabetes mellitus (DM) is a serious chronic metabolic
disease and be divided into two major types by etiology,
namely type1 diabetes mellitus (T1DM) or type2 diabetes
mellitus (T2DM). It is a global disease that a thorny prob-
lem in the world medicine. Increasing trend of greater
number and/or younger DM patients is for seen due to
greater prevalence of obesity and sedentary life style [1].* Correspondence: huj@fjtcm.edu.cn
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reproduction in any medium, provided the orDiabetes needs long-term treatments in order to have
their conditions brought under control and to prevent
complications. Exacerbate symptoms associated with
hyperglycemia is primarily attributed to microvascular and
macrovascular changes which can cause atherosclerosis,
retinopathy, renal failure, and peripheral artery diseases.
Once complications are allowed to creep in, the outcome
is in danger [2]. Commonly practiced pharmacologic treat-
ment of DM includes take hypoglycemic agents and insu-
lin. But to date, insulin cannot be used orally and its
repeated injections have many undesirable adverse effects.
There are many oral hypoglycemic agents for the treat-
ment of diabetes, such as biguanides and sulfonylureas;
biochemical drugs,such as insulin-secretagogues,insulinThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aldose reductase inhibitor, α-glucosidase inhibitors and
protein glycation inhibitor. However, intake of these drugs
also causes side effects, for example, hypoglycemia, lactic
acid intoxication, gastrointestinal upset, and are not effect-
ive in lowering the blood sugar in chronic diabetic patients
[3]. There is an increasing demand by patients for the use
of plant medicinal, folk medicine, traditional medicine of
ethnic minorities, as well as other dietary modulators to
help control the symptoms of diabetes [4-8].
In Chinese clinical medicine, “the diabetes mellitus”
belongs to the “wasting thirst sickness category”, which
is known as Xiaokezheng with respect to the sign of im-
balance of Yin, Yang and Qi. Patients usually suffer from
dryness of the mouth and increased thirst, blood stasis
and constipation [9]. The medicinal information on
traditional includes about 400 Chinese herbs, a number
of Chinese formulas, and Chinese patent medicines
used for controlling DM and its complications based on
the theories to tendency in eliminating heat nourishing
yin, then supplementing Qi and nourishing Yin [10,11].
Polysaccharides are the most abundant and the most di-
verse materials found on earth. Drugs and health foods
made of polysaccharides have been a research hotspot in
the field of life sciences. Polysaccharides feature promin-
ently anti-diabetes in many Chinese herbs. Radix astragali,
radix pseudostellariae are considered of utmost impor-
tance two herbs in traditional medicine to treat at DM. It
had been made a deep study that the structures and their
mechanism of radix astragali of polysaccharides anti-
diabetes [12]. Acanthopanax senticosus polysaccharide oral
administration had an efficacious amelioration effect on
the antioxidant status in alloxan-induced diabetic mice.
The polysaccharide from Salvia miltiorrhiza Bunge can
protect against the development of T2DM and improve
insulin resistance via reduction of oxidative stress. The
polysaccharide from Ophiopogon japonicus possess potent
antioxidant activity and can protect the liver and kidneys
from the injurious effects of diabetes [13,14]. These were
believed, through pharmacological studies, that herb poly-
saccharides restore the functions of pancreatic tissues
causing an increase in insulin output by the functional
beta cells (β-cell), thus lower the blood glucose levels.
These polysaccharides have also been shown to improve
the sensitivity of peripheral cells to circulating insulin.
Pseudostellaria heterophylla (Miq.) Pax, as described
in the Pharmacopoeia of People’s Republic of China,
Strengthens Qi and generates Fluids. Use for lack of appe-
tite from deficient spleen; fatigue, palpitation, profuse
sweating; thirst from lung Yin deficiency [15]. In the previ-
ous studies, the major components of Pseudostellaria
heterophylla include volatile compounds, saponins, poly-
saccharides, cycle peptides, amino acids, minerals, etc.,
and these chemical compounds are related to diversebiological activities, such as suppressing cough, immuno-
logic enhancement and so on [16], it is widely used as
anti-diabetes drugs in Chinese clinical. Pseudostellariae
heterophylla is rich in polysaccharides. The crude polysac-
charide of Pseudostellaria heterophylla (PHP) effects on
glucose and lipid metabolism [17-19]. In the previous
studies, the researches in most cases pitched at a simple
level, but the benefits of R&D of PHP are potentially huge.
The feasibility of utilizing inflammatory markers in
screening T2DM risk can be substantiated from numerous
experimental, clinical and epidemiological observations
demonstrating that the ability of inflammatory factors to
predict the disease independently from established risk
factors. Overweight sets the stage for low-grade chronic
inflammation, with adiponectin levels decreasing while
resistin, FFAs and TNF-α increase. As overweight pro-
gresses to obesity, continued inflammation further leads to
elevated CRP, fibrinogen, IL-6, IL-1β and haptoglobin.
Obesity can be complicated by metabolic dysregulation
(metabolic syndrome) to develop frank T2DM where
LDL-cholesterol and triglyceride (TG) levels increase,
HDL-cholesterol levels deceases and hypertension and
IGT manifest. Throughout the pathologic continuum
from overweight to T2DM, insulin resistance increases
progressively. T2DM is linked to fourfold higher risk. Pub-
lic health initiatives aimed at preventing and controlling
T2DM should be targeted towards the early stages of the
disease, to prevent obesity and the cascade of inflamma-
tory events that eventually leads to the clinical manifest-
ation of T2DM [20].
It had been reported that PHP could decrease levels of
blood glucose on diabetic rats. Polysaccharide of different
molecular weight whether has same lower blood glucose
effects; this incited us to perform further studies on anti-
diabetic actions of the molecular weight size of polysac-
charides. In this paper, crude polysaccharide was degraded
to get three low molecular weight fractions and fed to type
1 diabetics mice induced by alloxan and type 2 diabetics
obese rats, on sweet, high-fat diet-induced by low dose
streptozotocin for 30 days. We accurately screen more ac-
tive hypoglycemic faction and detect lipid profiles and the
biomarkers such as pro-inflammatory cytokines and
chemokines to prospect novel strategies for polysaccha-
rides prevention diabetes mellitus.
Methods
Materials and reagents
Pseudostellaria heterophylla was provided from GAP
bases of Fujian Lijiexun Pharmaceutical Co., Ltd., Zherong
County, Fujian Province of China in 2010. The plant was
identified by Dr. M. Jin and a voucher specimen (No.
2010131037S) is deposited at the Fujian Provincial Insti-
tute for Drug Control, Fuzhou City, Fujian Province,
China. The plant material was dried in a ventilated oven at
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dards with different molecular weight (blue dextran, T10,
T40, T70, and T500) were purchased from Pharmacia (NJ,
USA). Bovine serum albumin, alloxan and streptozocin
were purchased from Sigma (MO, USA). Phenol, n-butyl
alcohol, chloroform, Coomassie brilliant blue G-250 and
sulfuric acids were purchased from Sinopharm Chemical
Reagent Co. (Shanghai, China). All reagents and solvents
were of analytical reagent grade and used without further
purification unless otherwise noted. All aqueous solutions
were prepared using newly double-distilled water.Preparation of crude polysaccharide and
ethanol classification
The polysaccharide was extracted by water and alcohol pre-
cipitation method. The dried medicinal materials was pul-
verized and passed through a 40-mesh sieve. The sample
powder was immersed in 85% ethanol for 1 h (1:8, m/v)
and extracted under reflux for three time (every 2 h). Dregs
were extracted with water (1:8, m/v) for three times (every
2 h). Then the extractions were filtered and the combined
filtrate was centrifuged at 4000 rpm for 10 min to remove
the residues. The supernatant was concentrated to 1/20
volume in a rotary evaporator under reduced pressure and
precipitated with 90% ethanol. The precipitation was col-
lected by centrifugation and dissolved in warm water. The
crude polysaccharide fluid was deproteinized by Sevage
method with n-butyl alcohol: chloroform equal 25:5:1(v/v)
shaken the container for 5 min, placed to stratification and
then was centrifuged at 4000 rpm for 5 min. The super-
natant was concentrated to 1/10 volume in a rotary evapor-
ator under reduced pressure and precipitated with 90%
ethanol, put it in a resting position for 24 h and centrifuged
at 4000 rpm for 5 min. The precipitation was freeze-dried
to yield total polysaccharide powder from Pseudostellaria
heterophylla.
Total polysaccharide, that was crude polysaccharide,
abbreviated to PH-TP. PH-TP was dissolved in warm
water, were subjected to a sequential precipitation with
ethanol at 40%, 60% and 90% (the supernatant after pre-
cipitated by 60 percent of ethanol) to obtain three frac-
tions of FP40, FP60 and FP90 (the small molecules
polysaccharide). Two or more polysaccharides are
expressed in PHPs.Analysis of components in polysaccharide
At 110°C temperature for 6 h, polysaccharide was hydro-
lyzed by 2 mol/mL trichloroacetic acid. High performance
liquid chromatography (HPLC) method with pre-column
derivatization was established for the determination of the
monosaccharides of PHP from the hydrolyzate and their
weight percentage content.Determination of the polysaccharide content and
molecular weight
Polysaccharide was deproteinized by repeated freeze-thaw
method. The total sugars were determined by the phenol-
sulphuric acid method with d-glucose as standard. The
soluble protein was determined by the Coomassie brilliant
blue G-250 method with bovine serum albumin as a
standard. Sephadex G-100 gel filtration chromatography
column (1 cm× 50 cm, 1 cm × 80 cm), a Model DBS-160
automatic collector, and Model TBP-50A constant flow
pump were used. The mobile phase was 0.5 mol/L NaCl
with flow rate of 0.3 ml/min, which dextrans (blue dex-
tran, T10, T40, T70, and T500) were used as references,
drew the standard curve from. The average molecular
weights (MW) of PHPs were determined.
Production of diabetes model and experimental design
Wistar rats and KM mice were used for the animal model
experiment, purchased from Shanghai SLAC Laboratory
Animal Co., Ltd. (License number: SCXK (Shanghai)
2009–0005). Animals were housed in an environmentally-
controlled room at a temperature of 22 ± 1°C, relative hu-
midity 65-70% with feed and water ad libitum. The animal
studies were approved by the Fujian Institute of Trad-
itional Chinese Medicine Animal Ethics Committee,
Fuzhou, China (No. FJZYY-AEEI 2010012). The experi-
mental procedures were carried out in accordance with
the Guidelines for Animal Experimentation of Fujian Uni-
versity of Traditional Chinese Medicine (Fuzhou, China).
Type 1 diabetic model
Male KM mice, weighing 18–22 g, were injected with
ALX 95 mg/kg b.w. injection in caudal vein route. Blood
sugar levels were estimated after 3 days to establish type
1 diabetic model; this also was non obese diabetes
(NOD) [21]. Mice having sugar level>20 mmol/L were
selected for experiments.
Type 2 diabetic model
Adult male Wistar rats were fed with high-fat and high-
sugar diet (Feed formula: by 10% lard, 2.5% cholesterol,
1% sodium cholate, 20% sucrose, and 66.5% of the basic
feed). Rats were injected with STZ in citrate buffer
(pH 4.5) at a dose below 50 mg/kg b.w. in abdomen route
after 4 weeks to establish type 2 diabetic model; this also
was high fat diabetes (HFD) [21]. Rats having sugar
level>11.1 mmol/L were selected for experiments.
Experimental groups
Fourteen groups of mice/rats, ten in each received the
following treatment schedule. Mice treated with polysac-
charide which was administrated at high dose of 4 g/kg
(HD), moderate dose of 2 g/kg (MD), and low dose of
1 g/kg (LD). Rats treated with polysaccharide which was







PH-TP 0.25 44.40 7.0 × 103 ~ 2.1 × 105
PF40 0.19 47.28 5.2 × 104 ~ 2.1 × 105
PF60 0.21 41.08 1.0 × 104 ~ 2.1 × 105
PF90 0.17 45.89 3.0 × 103 ~ 6.8 × 103
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1.5 g/kg, and low dose of 0.5 g/kg.
Group I: (Control) normal mice or rats.
Group II: (Diab.) ALX or STZ induced diabetic model.
Group III: (Positive) animals were given metformin
0.23 g/kg (mice), 0.15 g/kg (rats).
Group IV: (PH-TP) diabetic animals treated with
PH-TP, HD, MD, and LD.
Group V: (PF40) diabetic animals treated with
PF40-HD, PF40-MD, and PF40-LD.
Group VI: (PF60) diabetic animals treated with
PF60-HD, PF60-MD, and PF60-LD.
Group VII: (PF90) diabetic animals treated with
PF90-HD, PF90-MD, and PF90-LD.
Assay of glucose level and lipid profiles
The blood glucose, total cholesterol (TC), triglyceride
(TG), low density lipoprotein (LDL), and high density
lipoprotein (HDL) were determined, respectively. All the
manipulations followed the directions of the commer-
cially available kits (Jiancheng Institute of Biotechnology,
Nanjing, China). The operation according to specifica-
tion and results were expressed in mmol/L.
Oral glucose tolerance and insulin tolerance test
The glucose tolerance test (OGTT) evaluates the ability to
respond appropriately to a glucose challenge. OGTT was
conducted in control and treated rats, after overnight fast,
blood samples were collected from the rats’ tail vein (con-
trol and treated groups) to obtain baseline blood glucose
levels. Subsequently, all the rats in groups were fed with
glucose (2 g/kg b.w.). Blood samples were taken by distal
venesection of the tail vein at interval of 30 min up to 2 h
for glucose estimation.
Insulin tolerance test (ITT) evaluates insulin sensitivity.
After overnight fast, blood samples were collected from
the rats’ tail vein (control and treated groups) to obtain
baseline blood glucose levels. Rats were injected with insu-
lin at a dose of 1.0 u/kg b.w. in abdomen route, blood
samples were taken by distal venesection of the tail vein at
interval of 30 min up to 2 h for glucose estimation.
Biomarker analysis associated with diabetes by multiplex
sandwich-ELISA
Collect venous blood in a hard plastic. Allow blood to clot
at room temperature for 1 hour. Centrifuge the specimen
at 1,600 × g for 15 minutes then carefully pipette the clear
serum (supernatant) to a clean specimen tube using a
Pasteur pipette. Aliquot into pre-labeled plastic, screw-cap
vials and store at −80°C, avoid freeze-thaw cycles.
This test includes 7 analytes, C-reactive protein (CRP),
adiponectin (Acrp30), interleukin-1beta (IL-1β), interleukin-
1beta (IL-10), Leptin, and tumor necrosis factor (TNF-α).Multiplex Protein Biomarker Testing Systems were
used in this testing project. This is a multiplex
sandwich-ELISA in a planar, plate-based array format,
including SignatureLUS CCD Imaging and ProArray
Analysis System. Arrays used in this test were Aushon
Rat Custom Array Kit, catalog No. 85849 (Rat IL-1β,
IL-2, IL-10, Leptin, TNF-α, Acrp30, CRP).Statistical analysis
Differences in measurement data were compared with the
analysis of variance test using SPSS/11.5 software. P values
of less than 0.05 were considered to indicate a significant
difference between treatments. All values are expressed as
mean ± SD.Results and discussion
Components and molecular weight of polysaccharides
The content of total sugar and protein of four PHPs were
41.08-47.28% and 0.17-0.25%, respectively. There were no
significant differences in total polysaccharide content and
protein contents of samples precipitated by different con-
centrations of alcohol. However, a notable difference was
observed in the range of molecular weight of polysacchar-
ide. Protein had been removed nearly; total sugar content
was superior to protein content, indicating that the extrac-
tions by this method could be recognized as polysaccha-
rides. The molecular weight distribution of polysaccharide
ranged from 3.0 kDa to 212 kDa, the polysaccharides in 4
samples were determined, as shown in Table 1. Further re-
search on hypoglycemic constituent in crude polysacchar-
ide is by this paper.
According to the chromatographic peak of monosaccha-
rides reference substance and samples, the composition of
the monosaccharides in PHP was identified. HPLC analysis
showed that polysaccharides of consists of galacturonic acid,
glucose, galactose and arabinos; their weight percentage
content was about 8.21%, 85.97%, 2.59%, 3.23%, respectively.
Different molecular weight polysaccharides are composed of
4 monosaccharides, but different in content. The retention
time (Rt) with each chromatographic peak was galacturonic
acid 13.22, glucose 29.54, galactose 33.13 and arabinos
























Figure 1 The chromatogram of 4 kinds of monosaccharides (blue-reference substance and black-PHF40 sample); the peaks from left to
right were PMP, galacturonic acid, glucose, galactose and arabinos in the order of retention time.
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Blood glucose level of type 1 diabetic mice
Blood glucose level was monitored using biochemistry
analyzer on 0, 15th, and 21st day, blood samples were
taken from retro orbital plexus. Blood glucose levels in
type 1 diabetic mice were raised to 50 mmol/L as com-
pared to normal control group mice on starting (0)
day. After oral administration of PH-TP, PF40, PH60,
and PH90 for 15 days, the elevated glucose levels
remained static in four polysaccharide groups. 30th
day, at the end of treatment the value in the high dos-
age of polysaccharides, blood glucose level of diabetic
mice moderately attenuate, were significantly diffe-
rences compare with model control group (p<0.05).
Compare with positive control group, but with little
success (Table 2).Table 2 Blood glucose level of type 1 diabetic mice and type
Groups Doses
T1DM mice blood glucose levels(mmol/L) Re
mod
(3
Day 0 Day 15 Day 30
Normal control 7.7 ± 1.2 6.7 ± 1.6 5.4 ± 2.3
Model control 52.1 ± 7.6 51.3 ± 10.4 42.6 ± 2.8
Positive control 62.5 ± 9.8 24.4 ± 4.9 10.4 ± 6.0** ↓
PH-TP H 54.6 ± 3.1 52.2 ± 1.6 37.9 ± 5.5* ↓
M 56.0 ± 2.4 51.8 ± 6.8 48.8 ± 7.1C ↑
L 56.8 ± 2.8 50.1 ± 5.2 40.1 ± 5.3C ↓
PF40 H 52.9 ± 5.5 50.8 ± 4.3 37.5 ± 8.7* ↓
M 51.2 ± 4.1 49.4 ± 3.5 34.2 ± 8.0* ↓
L 50.2 ± 6.3 47.6 ± 7.1 40.4 ± 7.3C ↓
PF60 H 52.8 ± 6.6 49.9 ± 2.7 37.4 ± 11.3* ↓
M 54.9 ± 6.5 47.2 ± 4.1 40.1 ± 4.1C ↓
L 51.7 ± 1.1 45.3 ± 5.9 41.5 ± 3.6C ↓
PF90 H 50.7 ± 1.3 50.5 ± 4.8 40.2 ± 14.3C ↓
M 56.3 ± 2.0 52.4 ± 5.7 39.5 ± 5.0 C ↓
L 52.2 ± 0.99 47.6 ± 7.5 39.8 ± 5.2C ↓
Values are expressed as mean ± S.d., n = 10.
Significantly different from the model group at* P ≤ 0.05, ** P ≤ 0.01.
Cversus model is NOT different.
The sign “↓” expresses fall and “↑” expresses rise.Blood glucose level of type 2 diabetic rats
The raised levels of blood glucose declined sharply after
oral administration of Metformin, PH-TP, PF40, PF60, and
PF90. When comparisons were made between 0 day, and
30th day of treated groups, there was highly statistically sig-
nificant (P<0.01) decline in blood glucose levels, as shown
in Table 2. If decline in blood glucose levels is to be the
only indices, then treatment with PH-TP, PF40, PF60, PF90,
and Metformin were highly effective in causing significant
anti-hyperglycemic response in this strain of rats. As far as
the relative efficacy is concerned, though all the four poly-
saccharides were extremely effective, PF40 has been proven
the highest anti-hyperglycemic activity among all. There
had been ever so little difference between the high dose of
PF40 and Metformin, but small molecule polysaccharide




T2DM rats blood glucose levels(mmol/L) Relative to
model control
30th day
Day 0 Day 15 Day 30
5.7 ± 2.1 5.60 ± 0.28** 3.91 ± 1.38**
23.9 ± 6.6 19.77 ± 3.69 25.10 ± 0.61
75.58% 23.5 ± 4.8 14.04 ± 2.55** 6.72 ± 1.57** ↓73.22%
11.03% 25.0 ± 2.4 18.69 ± 4.22c 14.84 ± 2.41** ↓40.87%
14.55% 24.2 ± 2.5 16.73 ± 2.95c 16.67 ± 2.41** ↓33.59%
5.87% 23.4 ± 5.8 16.68 ± 2.69c 12.95 ± 0.92** ↓48.41%
11.97% 24.0 ± 5.7 15.78 ± 5.05* 6.78 ± 5.47** ↓72.99%
19.72% 25.2 ± 3.1 15.82 ± 3.67* 11.41 ± 2.89** ↓54.54%
5.16% 23.3 ± 6.9 15.25 ± 1.95* 12.80 ± 1.15** ↓49.00%
12.21% 24.0 ± 4.4 19.82 ± 6.98c 13.73 ± 5.24** ↓45.30%
5.87% 23.7 ± 5.1 16.05 ± 2.85* 14.98 ± 6.05** ↓40.32%
2.58% 24.7 ± 1.1 12.99 ± 3.66* 12.82 ± 4.97** ↓48.92%
5.63% 23.9 ± 1.3 16.31 ± 2.24* 14.77 ± 3.73** ↓41.16%
7.27% 25.3 ± 2.0 15.13 ± 2.53* 14.83 ± 2.29** ↓40.92%
6.57% 22.2 ± 0.99 16.74 ± 2.33c 17.08 ± 3.56** ↓31.95%
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After treatment with the most effective PF40 at three
doses of high, medial, and low i.g. for 30 days, serum insu-
lin, TG, TC, HDL-C, LDL-C were also determined. The
level of insulin in the serum showed that insulin resistance
in T2DM rat was ameliorated after PHF40-HD treated
same as positive control group. There was a statistically
significant (P<0.01) decrease in serum triglycerides (TG)
below 2 mmol/L, but increase in serum high-density lipo-
protein (HDL-C) exceed 1.4 mmol/L. Total cholesterol
(CHOL) and low-density lipoprotein (LDL-C) versus
model is not different. Treatment with Metformin for
30 days, positive control group rats compared to model
control group rats, significantly decreased TG lever
(P<0.01), yet the HDL-C lever remains unchanged in
serum. PF40 did not have any effect on total cholesterol
(TC) content in the serum (Table 3). The results indicated
that PHF40 exhibited diverse effects on lipid metabolism.
OGTT and ITT
After all the rats in groups were fed with glucose, serum
samples were collected and detected at interval of 30 min
up to 2 h. Blood glucose levels (mmol/L) in model rats ele-
vated markedly in all time points with peaked at 30 min
(31.5 ± 1.3), but all PF40 groups more gently rise in the
blood glucose level than the model control group. Three
PF40 treated groups suppressed the increment of blood
glucose compared with model control group at 30 min
(19.2 ± 4.5 vs 31.5 ± 1.3, 20.4 ± 3.9 vs 31.5 ± 1.3, 21.6 ± 3.8
vs 31.5 ± 1.3) that had significantly differences (p<0.01). It
was regretted that PF40-HD, PF40-MD, and PF40-LD
groups, blood glucose of diabetic rats moved up sharply
with peaked at 60 min, the mean value of the glucose was
no differences detected between model control group and
treated groups. Either model group or PF40 groups, their
blood glucose no returned close to base line (model group
22.3 ± 2.8 to 28.5 ± 4.3, PF40-HD group 6.64 ± 3.2 to
25.8 ± 3.9, PF40-MD group 9.1 ± 3.1 to 27.6 ± 1.9, PF40-LD
group 10.7 ± 2.8 to 28.1 ± 1.3) and stop at a higher level
than their initial at 120 min. Among PF40 groups, the




Model control 18.83 ± 3.66 1.97 ± 0.3
Positive control 9.36 ± 2.43** 1.84 ± 0.3
PF40 H 10.27 ± 2.70** 2.19 ± 0.1
M 18.04 ± 3.91c 2.17 ± 0.3
L 18.55 ± 2.37c 2.38 ± 0.1
Values are expressed as mean ± S.d, n = 10.
Significantly different from the model group at* P ≤ 0.05, ** P ≤ 0.01.
Cversus model is NOT different.
The sign “↓” expresses fall and “↑” expresses rise.Where oral glucose tolerance test was concerned, the poly-
saccharide may not be very effective (Figure 2A).
After 30 days of treatment diabetic rats, the mean values
(mmol/L) of a basal glucose were model group with 19.0 ±
1.9, PF40-HD group 9.6 ± 5.3, PF40-MD group 10.3 ± 3.6,
PF40-LD group 11.9 ± 2.9, respectively. Injected insulin,
the level of blood glucose continued to drop. In three
PF40-treated groups were significantly lower than control
at 30 min. Similarly, lower than control at 60 min (p<0.05).
PF40 treatment improved glucose to regain a normal con-
dition at 120 min. Among PF40s-treated groups, the higher
dose-treated usually had more potent insulin tolerance
than that of the lower dose and medial dose why it de-
creased blood-sugar steadily avoid abnormally low blood
sugar usually resulting from excessive insulin (Figure 2B).
Multiplex protein biomarker analysis results
SearchLight Protein Array Technology is a multiplexing
sandwich-ELISA system based on chemiluminescent or
fluorescent detection of analytes whose respective capture-
antibodies are spotted in arrays within each well of a 96-
well microplate. Measure 7 biomarkers per microplate well
from 6 group rat’s serum samples displayed the concentra-
tion profiles by quantitative chemiluminescence. 8 spots
for standard curve, each standard sample test in triplicates.
Samples test in duplicates, control test in duplicates for
two different concentrations. CCD imaging from each plate
can be saved for a permanent record of raw experimental
data, shown in Figure 3A. Type 2 diabetic model rats, the
mean values of Acrp30 is lower than the blank control
group in serum (20.87 ± 1.28 vs 37.25 ± 2.57 μg/ml); after
treated with polysaccharide of PF40s, raise Acrp30 lever
have basically recovered (38.22 ± 4.63, medial dose of
PF40) which a medicinal effect get ahead of positive con-
trol. Type 2 diabetic model rats, raise the IL-1β in serum
when compared with blank control group (40.25 ± 18.25 vs
23.84 ± 2.91, pg/ml); yet the target have no transformed to
take PF40s. Innate immunoreactions was activated in
type 2 diabetic model rats, anti-inflammatory cytokines
IL-10 that have been increased in concentration in
serum (36.58 ± 19.48 vs. 17.80 ± 3.94, blank controlerum
TG HDL-C LDL-C
mmol/L mmol/L mmol/L
1 2.22 ± 0.72 1.29 ± 0.22 0.48 ± 0.06
2 C 1.52 ± 0.27**↓ 1.14 ± 0.29 C 0.44 ± 0.05C
9 C 1.59 ± 0.23**↓ 1.45 ± 0.15**↑ 0.43 ± 0.05C
8 C 1.98 ± 0.44**↓ 1.40 ± 0.27**↑ 0.42 ± 0.07C
1 C 2.03 ± 0.43*↓ 1.51 ± 0.07**↑ 0.48 ± 0.03C





















































Figure 2 The results of OGTT and ITT. A. The result of Oral
glucose tolerance test. B. The result of injecting insulin
tolerance test.
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increment suggested that they have obvious significant
anti-inflammatory effects; the metformin and PF40-HD
group, the levels of serum IL-10 were markedly in-
creased reaching 63.36 ± 13.42 and 52.57 ± 17.49 pg/ml
(p<0.01), see Figure 3B. Type 2 diabetic model rats,
TNF-α is higher than the blank control group in serum
(293.12 ± 41.67 vs. 114.10 ± 17.95, pg/ml), treated with
PF40-LD got significantly differences with a negative in-
crement 120.20 pg/ml (p<0.05), but curative effect of
metformin is not good. Type 2 diabetic model rats, has
a much higher leptin lever than blank control group
(707.40 ± 106.07 vs. 298.24 ± 65.54); dropped to 303.16 ±
50.46 pg/ml had markedly differences after PF40-LD treat-
ment (p<0.01), similar to metformin (310.00 ± 92.23 pg/ml).
CRP is an acute phase reactant that increases markedly in
response to inflammation, elevated serum CRP has been
associated with an increased risk of type 2 diabetes.
Rats took PF40s and fundamentally the CRP remainsunchanged, that was no significantly differences compare
with model control (Figure 3C). The concentration of IL-2
in serum was below quantification limit.
Conclusions
Alloxan is one of the chemical agents that high lose of it
used for the induction of type 1 diabetes mellitus in animal,
alloxan has been found to be selectively toxic via GLUT2
into a pancreatic beta cell as it preferentially accumulates
in theβ-cells as glucose analogues [22]. Type 1 diabetic
mice were administered varied molecular weight polysac-
charides from Pseudostellaria heterophylla on a diet for
21 days. The high does of PH-TP (from 7 to 210 kDa), the
high and medial does of PF40 (from 50 to 210 kDa), and
the high does of PF60 (from 10 to 210 kDa) lowered the
levels of blood glucose as average were about 11.3 per cent
lower than T1DM mice (p<0.05). It suggesting that they
impossibly had the best effect to repair β-cell function, fur-
thermore PF90 (from 3 to 6.8 kDa) was ineffective.
High-fat-diet/low lose of streptozotocin used for the
induction of T2DM animal model characterized by ab-
normal metabolism of carbohydrates, fats and proteins,
which is attributable to decreased insulin sensitivity
leading to insulin resistance [2]. This paper has explored
the PHPs effect on insulin resistance, adiponectin, leptin
and inflammatory markers in type 2 diabetic rats.
Varied molecular weight polysaccharides from
Pseudostellaria heterophylla oral administration to
streptozotocin-induced T2DM rats, they were all able
to significantly lower blood glucose. One of the four
polysaccharides was the most effective, which was PF40
with molecular weight from 50 to 210 kDa. It could re-
verse the hyperglycemia and hyperlipemia status. ITT
may be a useful method for assessing insulin resistance
(IR) and predicting the effectiveness of insulin sensi-
tizers [23]. The post-treatment in PF40 groups, in which
insulin was given and blood glucose was measured at
regular intervals. Thirty minutes after the insulin is ad-
ministered, blood glucose level was lower but not less
than half of the fasting glucose level. Glucose levels usu-
ally return to normal after about 90 minutes.
IL-10 is a pleiotropic cytokine inhibits the release of pro-
inflammatory cytokines and counteracts the inflammatory
process in order to re-establish homeostasis. Our experi-
ments show that as IL-10 down-regulates the production of
proinflammatory cytokines, the higher IL-10 levels were ob-
served in obese type 2 diabetic rat models represent an
attempt to inhibit continued proinflammatory cytokine pro-
duction. The post-treatment in PF40 groups, the levels of
the anti-inflammatory cytokine IL-10 were elevated continu-
ously in T2DM rats. High TNF-α is related to the patho-
physiology of IR and T2DM. TNF-α level was higher in rats
with T2DM. The average level of TNF-α in PF40 groups
were significantly lower than that in the model group. CRP
Standards
SamplesA   
B
C
Figure 3 The testing results of biomarkers of rats serum with multiplexing sandwich-ELISA method. A. Serum was filled in 96-well plate
collected CCD images of biomarkers from a ProArray Analysis System. Respective capture-antibodies are spotted in arrays within each well. 8
spots are for standard curve, each standard sample test in triplicates (left area). 6 group rat’s serum samples displayed the concentration profiles
by quantitative chemiluminescence (right area). Samples test in duplicates, control test in duplicates for two different concentrations. B. The
analysis results of 3 biomarkers Acrp30, IL-1β, and IL-10 in serum of T2DM rats after Pseudostellaria heterophylla polysaccharide (PF-40) treatment.
C. The analysis results of 3 biomarkers CRP, TNF-α and leptin in serum of T2DM rats after Pseudostellaria heterophylla polysaccharide
(PF-40) treatment.
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under the stimulation of adipocyte-derived IL-6 and TNF-α.
A major mechanism by which CRP plays a critical role in
T2DM is primarily by its action on pancreatic β-cell. Ele-
vated glucose levels impair islet function and survival, and it
has been proposed that intraislet expression of IL-1β con-
tributes to glucotoxicity [24]. But it is a pity that the levels of
CRP and IL-1β no changed after PF40 groups’ treatment.
Adiponectin (also known as Adipocyte complement-
related protein of 30 kDa, Acrp30) is an adipocyte-derived
protein with wide ranging paracrine and endocrine effects
on metabolism and inflammation [25]. Insulin sensitivity
is negatively correlated with obesity in type 2 diabetes,
PF40 significantly increased the level of Acrp30 to pro-
mote adipocyte differentiation and fatty acid catabolism
resulted that insulin was more sensitive. Leptin’s role inobesity prevents insulin resistance as novel therapeutic in-
terventions of T2DM [26]. Although leptin in serum was
increased in obesity T2DM rats, PF40 groups display re-
duced significantly it.
At present, in academic circles reach a consensus about
the etiological factors of T2DM are complicated, and is hard
to be treated. Our experiments show that Pseudostellaria
heterophylla polysaccharide with the range of molecular
weight is about 50 ~ 210 kDa (PF40) that could not only sig-
nificantly lower blood sugar but also improve insulin toler-
ance. Increased the lever of anti-inflammatory cytokines IL-
10 instead reduce inflammatory cytokines TNF-α to inhibit
chronic low grade inflammation of the T2DM. Besides, PF40
could elevate the level of Acrp30 and reduce leptin and total
triglyceride level in serum to regulate the disorder of fat me-
tabolism of the T2DM. To compare with positive control
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in serum, PF40 even had a much better effect. The content
of leptin in serum had no difference between metformin
with PF40. These demonstrated that PF40 can protect
against the development of T2DM and improve IR via slow
down overweight progress. We believe that polysaccharide
of Pseudostellaria heterophylla is a promising anti-diabetic
substance that will be helpful for the treatment of T2DM.
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